AbbVie Inc. (ABBV) Earnings Dates & History
NYSE·Healthcare·Drug Manufacturers - General
$227.14
+1.05%
Mkt Cap $401.47B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Apr 29, 2026 | $14.72B | $15.00B | +1.93% | $2.69 | $2.65 | -1.49% |
| Q1 2026 Feb 4, 2026 | $16.41B | $16.62B | +1.25% | $2.65 | $2.71 | +2.26% |
| Q4 2025 Oct 31, 2025 | $15.59B | $15.78B | +1.22% | $1.77 | $1.86 | +5.08% |
| Q3 2025 Jul 31, 2025 | $15.03B | $15.42B | +2.62% | $2.88 | $2.97 | +3.13% |
| Q2 2025 Apr 25, 2025 | $12.93B | $13.34B | +3.22% | $2.38 | $2.46 | +3.36% |
| Q1 2025 Jan 31, 2025 | $14.83B | $15.10B | +1.82% | $2.98 | $2.16 | -27.52% |
| Q4 2024 Oct 30, 2024 | $14.28B | $14.46B | +1.24% | $2.92 | $3.00 | +2.74% |
| Q3 2024 Jul 25, 2024 | $14.02B | $14.46B | +3.14% | $2.57 | $2.65 | +3.11% |
| Q2 2024 Apr 26, 2024 | $11.93B | $12.31B | +3.19% | $2.26 | $2.31 | +2.21% |
| Q1 2024 Feb 2, 2024 | $12.98B | $14.30B | +10.20% | $2.76 | $2.79 | +1.09% |
| Q4 2023 Oct 27, 2023 | $13.67B | $13.93B | +1.87% | $2.86 | $2.95 | +3.15% |
| Q3 2023 Jul 27, 2023 | $13.52B | $13.87B | +2.58% | $2.79 | $2.91 | +4.30% |
| Q2 2023 Apr 27, 2023 | $12.17B | $12.22B | +0.47% | $2.44 | $2.46 | +0.82% |
| Q1 2023 Feb 9, 2023 | $15.33B | $15.12B | -1.37% | $3.54 | $3.60 | +1.69% |
| Q4 2022 Oct 28, 2022 | $14.96B | $14.81B | -0.99% | $3.56 | $3.66 | +2.81% |
| Q3 2022 Jul 29, 2022 | $14.66B | $14.58B | -0.56% | $3.31 | $3.37 | +1.81% |
| Q2 2022 Apr 29, 2022 | $13.61B | $13.54B | -0.55% | $3.14 | $3.24 | +3.18% |
| Q1 2022 Feb 2, 2022 | $14.95B | $14.89B | -0.44% | $3.29 | $3.31 | +0.61% |
| Q4 2021 Oct 29, 2021 | $14.35B | $14.34B | -0.08% | $3.23 | $3.33 | +3.10% |
| Q3 2021 Jul 30, 2021 | $13.96B | $13.96B | +0.00% | $3.11 | $3.11 | +0.00% |
| Q2 2021 Apr 30, 2021 | $12.81B | $13.01B | +1.58% | $2.77 | $2.95 | +6.50% |
| Q1 2021 Feb 3, 2021 | $13.73B | $13.86B | +0.96% | $2.85 | $2.92 | +2.46% |
| Q4 2020 Oct 30, 2020 | $12.63B | $12.90B | +2.17% | $2.75 | $2.83 | +2.91% |
| Q3 2020 Jul 31, 2020 | $9.76B | $10.43B | +6.85% | $2.24 | $2.34 | +4.46% |
| Q2 2020 May 1, 2020 | $8.01B | $8.62B | +7.56% | $2.25 | $2.42 | +7.56% |
| Q1 2020 Feb 7, 2020 | $8.63B | $8.70B | +0.91% | $2.19 | $2.21 | +0.91% |
| Q4 2019 Nov 1, 2019 | $8.37B | $8.48B | +1.30% | $2.29 | $2.33 | +1.75% |
| Q3 2019 Jul 26, 2019 | $8.07B | $8.26B | +2.26% | $2.21 | $2.26 | +2.26% |
| Q2 2019 Apr 25, 2019 | $7.50B | $7.83B | +4.39% | $2.05 | $2.14 | +4.39% |
| Q1 2019 Jan 25, 2019 | $8.48B | $8.30B | -2.06% | $1.92 | $1.90 | -1.04% |
| Q4 2018 Nov 2, 2018 | $7.77B | $8.24B | +5.94% | $2.02 | $2.14 | +5.94% |
| Q3 2018 Jul 27, 2018 | $8.15B | $8.28B | +1.52% | $1.98 | $2.00 | +1.01% |
| Q2 2018 Apr 26, 2018 | $7.59B | $7.93B | +4.47% | $1.79 | $1.87 | +4.47% |
| Q1 2018 Jan 26, 2018 | $7.53B | $7.74B | +2.78% | $1.44 | $1.48 | +2.78% |
| Q4 2017 Oct 27, 2017 | $6.90B | $7.00B | +1.44% | $1.39 | $1.41 | +1.44% |
| Q3 2017 Jul 28, 2017 | $6.85B | $6.94B | +1.43% | $1.40 | $1.42 | +1.43% |
| Q2 2017 Apr 27, 2017 | $6.44B | $6.54B | +1.59% | $1.26 | $1.28 | +1.59% |
| Q1 2017 Jan 27, 2017 | $6.80B | $6.80B | +0.00% | $1.20 | $1.20 | +0.00% |
| Q4 2016 Oct 28, 2016 | $6.38B | $6.43B | +0.83% | $1.20 | $1.21 | +0.83% |
| Q3 2016 Jul 29, 2016 | $6.14B | $6.45B | +5.00% | $1.20 | $1.26 | +5.00% |
| Q2 2016 Apr 28, 2016 | $5.85B | $5.96B | +1.77% | $1.12 | $1.15 | +2.68% |
| Q1 2016 Jan 29, 2016 | $6.34B | $6.40B | +0.89% | $1.12 | $1.13 | +0.89% |
| Q4 2015 Oct 30, 2015 | $5.68B | $5.94B | +4.63% | $1.07 | $1.13 | +5.61% |
| Q3 2015 Jul 24, 2015 | $5.37B | $5.47B | +1.89% | $1.06 | $1.08 | +1.89% |
| Q2 2015 Apr 23, 2015 | $4.56B | $5.04B | +10.59% | $0.84 | $0.94 | +11.90% |
| Q1 2015 Jan 30, 2015 | $5.27B | $5.45B | +3.49% | $0.85 | $0.89 | +4.71% |
| Q4 2014 Oct 31, 2014 | $4.34B | $5.02B | +15.58% | $0.78 | $0.89 | +14.10% |
| Q3 2014 Jul 25, 2014 | $4.57B | $4.93B | +7.89% | $0.76 | $0.82 | +7.89% |
| Q2 2014 Apr 25, 2014 | $4.37B | $4.56B | +4.41% | $0.68 | $0.71 | +4.41% |
| Q1 2014 Jan 31, 2014 | $5.11B | $5.11B | +0.00% | $0.82 | $0.82 | +0.00% |
| Q4 2013 Oct 25, 2013 | $4.43B | $4.66B | +5.13% | $0.78 | $0.82 | +5.13% |
| Q3 2013 Jul 26, 2013 | $4.52B | $4.69B | +3.80% | $0.79 | $0.82 | +3.80% |
| Q2 2013 Apr 26, 2013 | $4.27B | $4.33B | +1.49% | $0.67 | $0.68 | +1.49% |
| Q1 2013 Mar 15, 2013 | — | $5.21B | — | — | $0.96 | — |
| Q1 2013 Jan 23, 2013 | — | $4.51B | — | $0.99 | $1.00 | +1.01% |
| Q2 2012 Jun 30, 2012 | — | $4.49B | — | — | $0.78 | — |
| Q1 2012 Mar 31, 2012 | — | $4.17B | — | — | $0.54 | — |
| Q4 2011 Dec 31, 2011 | — | $4.86B | — | — | $0.73 | — |
| Q3 2011 Sep 30, 2011 | — | $4.41B | — | — | $0.01 | — |
| Q2 2011 Jun 30, 2011 | — | $4.27B | — | — | $0.97 | — |
| Q1 2011 Mar 31, 2011 | — | $3.90B | — | — | $0.45 | — |